Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
50 participants
OBSERVATIONAL
2025-01-31
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective SPINE Registry
NCT04176562
Investigation of DEXA-C Anterior Cervical Interbody System
NCT05883436
Lumbar Interbody Implant Study
NCT04418830
Postmarket Outcomes Study for Evaluation of the Superion™ Spacer
NCT04563793
Interbody Systems: Post Market Clinical Follow-up Study
NCT04911257
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Data collected in this study will be documented using summary tables and subject data listings. Continuous variables will be summarized using descriptive statistics, specifically the mean, median, standard deviation, minimum, and maximum, and a 95% confidence interval for the mean based on the t-distribution. Categorical variables will be summarized using frequencies, percentages, and 95% confidence intervals for the true proportions. Resultant of the observational study design, this evaluation is not powered to test a hypothesis. It is designed to yield supplemental long-term information in this real-world population.
The analysis will be stratified by lumbar and cervical patients. Additionally, each cohort will evaluate the following analysis populations:
Enrolled Population: This dataset will include all subjects who were screened and enrolled into the study.
Evaluable Population: This dataset will exclude subjects with ION 3D Facet Screw device improperly placed
To minimize the introduction of bias into this observational low risk evaluation, the following measures will be observed:
* Complete and accurate prespecified data shall be obtained,
* All cervical and all lumbar patients at a study site that were previously implanted with the ION 3D Facet Screw System will be reviewed for possible study inclusion (all-comers study design),
* All participants will be enrolled under the same study entrance criteria,
* All participants shall follow the same prospectively designed study protocol,
* Serious Adverse Event adjudication will be performed by independent blinded reviewer, and
* Radiographic measurements and CT assessments will be performed by blinded independent core lab.
In consideration of the retrospective nature of this investigation coupled with a possible 1-time prospective evaluation, data monitoring will not be performed. However, data edits and database checks will be built into the EDC system to minimize the potential for data entry errors. Further, TSN, as the entity responsible for overall study conduct/management, will review all data entered and ensure appropriate source documentation is available to support data extraction/collection.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cervical
Previously implanted bilaterally intra-facet with the SurGenTec ION 3D Facet Screw System at one or two contiguous levels of the cervical spine (C3-C7)
ION 3D Facet Screw System
Observational study of subjects previously implanted with ION 3D Facet Screw System.
Lumbar
Previously implanted bilaterally intra-facet with the SurGenTec ION 3D Facet Screw System at one or two contiguous levels of the lumbar spine (L3-S1)
ION 3D Facet Screw System
Observational study of subjects previously implanted with ION 3D Facet Screw System.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ION 3D Facet Screw System
Observational study of subjects previously implanted with ION 3D Facet Screw System.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must have supplemental fixation at the target level(s),
* Skeletally mature (minimum age of 21 years but not greater than 80 years),
* Be willing and able to comply with the study protocol requirements, and
* Be willing to sign the study-specific Informed Consent Document.
Exclusion Criteria
* Unilateral fixation with the ION Fact Screw System,
* Current tobacco use
* Body Mass Index of \>40,
* Current active or suspected malignancy, or a cancer diagnosis that was ongoing during the patient's treatment and healing period,
* Significant metabolic bone disease (diagnosis of osteoporosis or osteomalacia),
* Currently taking medications that are known to potentially interfere with bone healing (e.g. chronic oral/systemic steroids),
* Pregnant or nursing female, or
* Incarcerated at the time of the required 12-month evaluation.
21 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
SurGenTec LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Orthopaedics Northeast
Fort Wayne, Indiana, United States
Neuroscience Specialists
Oklahoma City, Oklahoma, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ION Facet RWE Study
Identifier Type: OTHER
Identifier Source: secondary_id
TSN-2024-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.